CAN FITE (Israel) Today

Equity ratings for CAN FITE BIOPHARMA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of July 2021 and ending today, the 19th of September 2021. Click here to learn more.
CAN FITE BIOPHARMA cannot be verified against its exchange. It appears that CAN FITE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

CAN FITE Stock Profile

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. CAN FITE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 7 people.. The public information regarding CAN FITE BIOPHARMA's current market price is not available at this time.
CAN FITE BIOPHARMA is not yet fully synchronised with the market data
CAN FITE BIOPHARMA has some characteristics of a very speculative penny stock
CAN FITE BIOPHARMA has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.49 M. Net Loss for the year was (6.68 M) with profit before overhead, payroll, taxes, and interest of 3.82 M.
CAN FITE BIOPHARMA has accumulated about 3.21 M in cash with (4.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Legal NameCAN FITE BIOPHARMA
CEO, DirectorPnina Fishman  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of CAN FITE's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
CAN FITE BIOPHARMA (CANF) is traded on Tel Aviv Stock Exchange in Israel and employs 7 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.42 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CAN FITE's market, we take the total number of its shares issued and multiply it by CAN FITE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. CAN FITE BIOPHARMA operates under Healthcare sector and is part of Biotechnology industry. The entity has 0 outstanding shares. CAN FITE BIOPHARMA has accumulated about 3.21 M in cash with (4.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Check CAN FITE Probability Of Bankruptcy

CAN FITE Stock Against Markets

Picking the right benchmark for CAN FITE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CAN FITE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CAN FITE is critical whether you are bullish or bearish towards CAN FITE BIOPHARMA at a given time.
CAN FITE BIOPHARMA cannot be verified against its exchange. It appears that CAN FITE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CAN FITE stock to make a market-neutral strategy. Peer analysis of CAN FITE could also be used in its relative valuation, which is a method of valuing CAN FITE by comparing valuation metrics with similar companies.

CAN FITE Corporate Executives

Elected by the shareholders, the CAN FITE's board of directors comprises two types of representatives: CAN FITE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CAN FITE. The board's role is to monitor CAN FITE's management team and ensure that shareholders' interests are well served. CAN FITE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CAN FITE's outside directors are responsible for providing unbiased perspectives on the board's policies.
Check out Trending Equities. Note that the CAN FITE BIOPHARMA information on this page should be used as a complementary analysis to other CAN FITE's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Tools for CAN FITE Stock

When running CAN FITE BIOPHARMA price analysis, check to measure CAN FITE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAN FITE is operating at the current time. Most of CAN FITE's value examination focuses on studying past and present price action to predict the probability of CAN FITE's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CAN FITE's price. Additionally, you may evaluate how the addition of CAN FITE to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go